Here is how the COVID vaccine manufacturers are responding to the new variant.
What vaccine makers are saying about B.1.1.529 (cont):
-lab data will tell BioNTech whether B.1.1.529 could be an escape variant
-Pfizer/BioNTech can adapt mRNA vaccine within 6 weeks, ship initial batches within 100 days in event of escape variant (2/2)
— Meg Tirrell (@megtirrell) November 26, 2021
What vaccine makers are saying about B.1.1.529 – now Omicron (cont):
-Novavax "has already initiated development of a new recombinant spike protein based on the known genetic sequence … and will have it ready to begin testing and manufacturing within the next few weeks." (4/2)
— Meg Tirrell (@megtirrell) November 26, 2021
Get ready for the second vaccine!
The Palmieri Report is a Pro-America News Outlet founded by Jacob Palmieri. The Palmieri Report is dedicated to giving people the truth so that they can form their own informed political opinions. You can help us beat Big Tech by following us on GETTR , Telegram, and Rumble.
